State actuarial reports confirm Flemington-Raritan's projected 40% health insurance increases reflect a statewide benefits system crisis, not isolated market volatility.

Discover what the story left out — data, context, and alternative perspectives
The most important thing this article omits is that Flemington-Raritan's health insurance cost shock is not a local anomaly or a broker's projection to be questioned — it is a documented, statewide structural collapse in New Jersey's public employee health benefit system. The School Employees' Health Benefits Program (SEHBP) is recommending a 31.9% total premium increase for Plan Year 2026 for active employees — comprising a 27.9% medical increase and a staggering 58.6% prescription drug increase. The article's reference to 35–40% increases, far from being inflated broker projections, is actually consistent with — and in some cases below — what state actuaries are formally recommending.
This context doesn't vindicate the article's framing, but it does reframe the question: the problem isn't whether to believe the numbers. The problem is that the structural forces driving those numbers are largely absent from public discourse.
---
The Claims Reserve Is Nearly Depleted
The SEHBP's Claims Stabilization Reserve (CSR) — the financial buffer that smooths premium volatility — has fallen 60% since 2023 and is projected to reach only 0.6 months of plan costs by end of 2025. The recommended minimum is 2.0 months. This is why increases are so sudden and severe: years of underfunding the reserve have compressed what should have been gradual increases into a single catastrophic adjustment. Districts like Flemington-Raritan are not facing a one-time spike — they are absorbing the accumulated cost of a system that has been running on fumes.
The Trend Lines Are Structural, Not Cyclical
Average annual cost growth in 2025 is exceeding 8% for medical services and 12–20% for prescription drugs across state health benefit programs. Trend assumptions built into SEHBP actuarial models set medical PPO growth at 7.0% and prescription drug trends at 12.5%, based on analysis from Aon and carrier recommendations from Horizon and Optum. These are not aberrations — they reflect a healthcare economy in which major New Jersey health systems are simultaneously undertaking massive capital expansions: Cooper Health broke ground on a $3 billion expansion in Camden, Morristown Medical Center is investing $1 billion in a new surgical tower, and Hackensack University Medical Center pulled in $1.67 billion in net patient revenue. Capital costs in healthcare systems flow downstream into the rates that insurers pay — and ultimately into premiums.
This Is a Statewide Fiscal Emergency
The SHBP-State group recorded a net loss of approximately $113 million in 2024, with prescription drug spending running 23.6% higher than projected. Over the past four years (2022–2025), SHBP-LG premiums have increased 59%, with combined increases across all plans reaching 44%. Health benefits for active state employees and higher education employees alone cost $2.0 billion annually — meaning a 10% increase in FY 2026 raised costs by over $180 million in a single year. Flemington-Raritan is one node in a system-wide crisis that the state has not yet resolved.
Other Municipalities Are Documenting the Same Trajectory
Seaside Park Borough — a small municipality, not a school district — documented employee group insurance costs rising from $387,100 in 2021 to $558,783 in 2025, a 44.4% increase over four years. This cross-sector parallel confirms that the cost pressures are not unique to education or to any single broker's projections.
---
The article's critique of emotional language — "dire," "mind-boggling," "disheartening" — is valid as a media criticism point. Journalism that relies exclusively on district officials without independent voices does limit public understanding. However, the implicit suggestion that the cost projections themselves deserve skepticism is not well-supported by the evidence. The 35–40% figures cited in the article align closely with the 31.9% formally recommended by state actuaries for SEHBP Plan Year 2026.
Where the article's critique does land is on broker transparency. Brown & Brown is presented as a neutral explainer, but the article correctly notes that compensation structure and conflicts of interest go undisclosed. This is a legitimate gap — brokers in the health insurance market are typically compensated through commissions tied to premium volume, creating a structural incentive that readers deserve to understand.
The article also correctly identifies the absence of Chapter 44 analysis. New Jersey's Chapter 44 constrains how districts can manage health benefit costs and which plans they can offer — understanding these constraints is essential to evaluating what flexibility actually exists. This is a genuine omission.
---
Rather than accepting the binary of "cut programs or raise taxes," informed attendees should press on:
1. Is the district in SEHBP or a private plan? If SEHBP, the 31.9% increase is a state-level determination with limited local negotiating room. If private (like Brown & Brown's placement), there is more room to shop coverage. 2. What is the district's claims history? Per-member cost projections for SEHBP active employees showed only a 3.8% increase through mid-year 2024 analysis. If Flemington-Raritan's own claims experience is favorable, that's a negotiating lever. 3. Has the district explored cost-shifting strategies? Out-of-pocket maximums for SEHBP plans have already increased — from $9,100/$18,200 (single/family) in 2023 to $9,200/$18,400 in 2025 — reflecting ongoing cost-shifting to employees. Further cost-sharing changes require contract negotiations. 4. What utilization management programs are in place? State guidance identifies reducing unnecessary utilization, encouraging proper network use, and shifting services to lower-cost sites as the primary mitigation levers available. 5. What is Brown & Brown's compensation structure? Specifically, does their fee increase with premium volume?
---
The statewide average health insurance cost is already $24,545 per employee annually, consuming 15% of the average school district budget. A 14% premium hike was already approved for 2025, with the 2026 recommendations now exceeding 30%. Meanwhile, Horizon Blue Cross Blue Shield — a dominant carrier in NJ public plans — generated over $14 billion in annual revenue, with its CEO earning $4.8 million, nearly 200 times a starting teacher's salary.
The structural forces here — depleted reserves, pharmaceutical inflation, hospital capital expansion, and insurer market concentration — operate well above the level of any school board meeting. Flemington-Raritan's special meeting matters, but the decisions that will actually determine the outcome are being made in Trenton and in the boardrooms of health systems and insurers. Community members deserve to understand that the local meeting is downstream of a much larger policy failure.